BioAtla

BioAtla is an American clinical-stage biopharmaceutical company that develops specific and selective antibody-based therapeutics for the treatment of various cancers. The company was founded in 2007 and is based in San Diego, California.
BioAtla stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

BioAtla balance sheet

Report period2018 2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

BioAtla cash flows

Report period2018 2019 2020 2021 2022 Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

BioAtla multipliers

Report period2018 2019 2020 2021 2022 Q3 23 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

BioAtla profitability

Report period2018 2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
EBITDA Margin
Operating margin
BioAtla assets
BioAtla cash flows

BioAtla dividend policy

The company doesn't provide dividend

BioAtla shares

TickerNameTypeNominal valueISINPrice
BCAB:USBioAtlaCommon share-US09077B1044$1.56
BioAtla news
03.03.2022
BioAtla's GAAP loss for 2021 was $95.402 million, up 1.66 times from $35.853 million in the previous year. Revenue fell 41.7% to $250,000 from $429,000 a year earlier.
Source: {source} pictogram bioatla.com
Pictogram next
18.11.2021
BioAtla's GAAP loss for 9M 2021 was $72.012 mln, up 3.7 times from $19.458 mln in the previous year. Revenue decreased 41.7% to $250,000 from $429,000 a year earlier.
Source: {source} pictogram bioatla.com
Pictogram next
13.08.2021
BioAtla's GAAP loss for 6M 2021 was $49.082 mln, up 6.3 times from $7.826 mln in the previous year. Revenues fell 10.4% to $250,000 from $279,000 a year earlier.
Source: {source} pictogram bioatla.com
Pictogram next
14.05.2021
BioAtla's GAAP loss for 3 months of 2021 was $18.701 million, up 12 times from $1.604 million in the previous year. The company received no revenue in the reporting period. A year earlier the indicator amounted to $89 thousand.
Source: {source} pictogram bioatla.com
Pictogram next
All BioAtla news
General information
Company nameBioAtla
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address11085 Torreyana Road San Diego, CA United States
Mailing address11085 Torreyana Road San Diego, CA United States
Websitewww.bioatla.com
Information disclosurewww.sec.gov